BMS-181885, a 5-HT(1B/1D) receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential

1998-06-26

European Journal of Pharmacology , Volume 351 - Issue 3 p. 329- 339

Additional Metadata
Keywords	Antimigraine drug, Arteriovenous anastomosis, BMS-181885, Carotid artery, Coronary artery, human, Human, Migraine, Pig, Sumatriptan
Persistent URL	doi.org/10.1016/S0014-2999(98)00325-2, hdl.handle.net/1765/63716
Journal	European Journal of Pharmacology
Organisation	Department of Pharmacology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Saxena, P. R., de Vries, P., Heiligers, J., Bax, W., Maassen van den Brink, A., & Yocca, F. (1998). BMS-181885, a 5-HT(1B/1D) receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential. European Journal of Pharmacology, 351(3), 329–339. doi:10.1016/S0014-2999(98)00325-2

Publication